2017
RAISED FUNDS
We raised 2 million Euros from
technology focused venture capital fund
ACT Venture Partners.
2021
GMP CERTIFICATION
Our production facility was
granted GMP license for clinical batch
lyophilized oncology drugs.
2021
CLINICAL TRIALS
In consequence of promising results from
pre-clinical studies, we started
RS-0139’s phase-I clinical trial in NSCLC.
2021
RAISED FUNDS
We raised 12 million USD in our
Series-A investment round from Gen İlaç,
OneLife Ventures and Eczacıbaşı Momentum.